BLACK DIAMOND THERAPEU
3.2250
08-November-24 13:23:45
15 minutes delayed
Stocks
+0.0450
+1.42%
Today's range
3.1600 - 3.3800
ISIN
N/A
Source
NASDAQ
-
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
09 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
08 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
26 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
06 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
09 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
03 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the Jefferies Global Healthcare Conference
06 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Appoints Sergey Yurasov, M.D., Ph.D., as Chief Medical Officer
01 Jun 2022 06:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the H.C. Wainwright Global Investment Conference
17 May 2022 06:00:01 By Nasdaq GlobeNewswire
-
12 May 2022 15:30:00 By Nasdaq GlobeNewswire
-
11 May 2022 15:30:00 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Announces Pipeline Prioritization and Workforce Realignment
25 Apr 2022 08:00:00 By Nasdaq GlobeNewswire
-
07 Apr 2022 15:30:00 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Appoints Wendy L. Dixon to its Board of Directors
07 Apr 2022 06:00:00 By Nasdaq GlobeNewswire
-
17 Mar 2022 16:00:00 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference
02 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Appoints Elizabeth Montgomery as Chief People Officer
22 Feb 2022 07:00:02 By Nasdaq GlobeNewswire
-
11 Jan 2022 06:00:00 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Announces Strategic Priorities and Expected Milestones for 2022
10 Jan 2022 06:00:02 By Nasdaq GlobeNewswire